Dr Lal PathLabs Adds Illumina's NovaSeq X Genome Sequencer To Genomics Division

Dr Lal PathLabs Ltd. has upgraded its genomics arm, Genevolve, with the addition of Illumina Inc.'s NovaSeq X series genome sequencing equipment, the diagnostics firm said in a press release Wednesday. The company did not disclose the investment value for the new machinery.

The addition of the advanced sequencing system is aimed at scaling the company’s genomic testing capacity and strengthening its presence in the precision diagnostics space. “This investment allows us to broaden our capabilities and contribute meaningfully to India's evolving genomics landscape,” the company said.

Genevolve was launched in 2019 as Dr Lal PathLabs’ DNA-based centre of excellence for sequencing. With the new platform, Genevolve will be able to conduct up to 20,000 genome sequencing projects per year, potentially enabling new discoveries and scientific breakthroughs, the company said.